P.2.f.021 The safety and tolerability of vortioxetine in treating adults with major depressive disorder after 52 weeks of open-label treatment
| Autor: | Baldwin, D.S., Mahableshwarkar, A.R., Chrones, L., Palo, W., Matz, J. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology October 2014 24 Supplement 2:S464-S464 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect